Sun Pharma Seeks RBI Relief to Smooth Path for Organon Acquisition

Sun Pharma is preparing to approach the Reserve Bank of India for an exemption under foreign remittance regulations as it moves forward with the Organon acquisition. This article explains the regulatory step, why it matters and what it could mean for investors, the pharma sector and cross border deals in India.